Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Caliper Settles Lawsuits with Carestream
Aug 2011
HOPKINTON, Mass., Aug. 9, 2011 — Caliper Life Sciences Inc. announced it favorably settled two lawsuits with medical imaging systems provider Carestream Health Inc. of Rochester, N.Y.

The first lawsuit, filed in February 2010, alleged that Carestream’s marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen, a wholly owned subsidiary of Caliper, by Stanford University.

In the second lawsuit, filed in July 2010, Carestream alleged that Caliper’s Lumina XR system infringed on US Patent No. 7,734,325.

To settle the lawsuits, both companies have agreed to dismiss their respective claims and counterclaims, Carestream has agreed not to market and sell in vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper, and Carestream will not assert that the Lumina system as currently configured and sold by Caliper infringes any of its patents.

Caliper Life Sciences provides technologies that enable researchers in the life sciences industry to create enhanced medical and diagnostic tests.

For more information, visit:  

AmericasBiophotonicsBusinessCaliper Life Sciences Inc.Carestream Health Inc.imagingImaging Diagnosticsimaging lawsuit settlementlife sciencesLumina XR systemMassachusettsmedical imagingNew YorkStanford UniversityUS Patent No. 7734325Xenogen

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.